WallStreetZenWallStreetZen

NASDAQ: SMMT
Summit Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SMMT past revenue growth

How has SMMT's revenue growth performed historically?
Company
-100%
Industry
146.32%
Market
18.14%
SMMT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SMMT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SMMT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$116.0M
Current Profit Margin
0%

SMMT Return on Equity

Current Company
-136.1%
Current Industry
54.9%
Current Market
28.2%
SMMT's Return on Equity (-136.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SMMT announces earnings.

SMMT Return on Assets

Current Company
-55.5%
Current Industry
16.6%
SMMT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SMMT Return on Capital Employed

Current Company
-75.66%
Current Industry
-49.2%
SMMT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SMMT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SMMT$0.00-$114.32M-$116.03M-100.00%N/A
FOLD$399.36M-$92.08M-$151.58M+34.35%N/A
ARWR$181.74M-$262.45M-$296.81M+30.90%N/A
IDYA$23.39M-$108.95M-$112.96M+58.18%N/A
IMCR$249.43M-$50.00M-$55.29M+53.19%N/A
View Top Biotech Stocks

SMMT earnings dates

Next earnings date
May 22, 2024

Summit Therapeutics Earnings & Revenue FAQ

What were SMMT's earnings last quarter?

On Invalid Date, Summit Therapeutics (NASDAQ: SMMT) reported Q1 2024 earnings per share (EPS) of -$0.00, up 92.86% year over year. Total Summit Therapeutics earnings for the quarter were -$43.47 million. In the same quarter last year, Summit Therapeutics's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Summit Therapeutics stock.

What was SMMT's earnings growth in the past year?

As of Q2 2024, Summit Therapeutics's earnings has grown year over year. Summit Therapeutics's earnings in the past year totalled -$116.03 million.

What is SMMT's earnings date?

Summit Therapeutics's earnings date is Invalid Date. Add SMMT to your watchlist to be reminded of SMMT's next earnings announcement.

What was SMMT's revenue last quarter?

On Invalid Date, Summit Therapeutics (NASDAQ: SMMT) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Summit Therapeutics's revenue was $0.00.

What was SMMT's revenue growth in the past year?

As of Q2 2024, Summit Therapeutics's revenue has grown -100% year over year. This is 246.32 percentage points lower than the US Biotechnology industry revenue growth rate of 146.32%. Summit Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.